LJI strengthens ties between U.S. and Mexican scientists
“We’re glad to continue our support for this cross-border partnership and expand our work with young scientists and research leaders just across the border.”
“We’re glad to continue our support for this cross-border partnership and expand our work with young scientists and research leaders just across the border.”
LJI scientists share their visions for more effective, longer-lasting vaccines
LA JOLLA, CA—An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2.
Key Findings: There are no vaccines or therapies available for lymphocytic choriomeningitis virus (LCMV) infection. This pathogen spreads easily and
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
LA JOLLA—Rabies virus kills a shocking 59,000 people each year, many of them children. Some victims, especially kids, don’t realize
Dawid Zyla, Ph.D., is an immunologist and a skilled photographer. He shares a stunning look at the technical marvels behind biomedical research.
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
5 takeaways from February's "Live from the Lab" webinar
Most coronaviruses usually cause the common cold, but, as happened with the SARS virus in 2003 and the MERS virus
They help us digest food, balance our immune system, and keep our hearts and brains healthy. But harmful viruses and